Replies to post #398630 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

People who follow our experts will reject prophylaxis.

The proof of concept [of this new test for toxic Amyloid ß-peptides] was achieved by testing 379 banked human plasma samples. SOBA detected Aß oligomers in patients on the AD continuum, including controls who later progressed to mild cognitive impairment.

If your elderly relative had this test and she tested positive for these Alzheimer’s peptides, but did not express any symptoms yet, having read the postings on this board you would certainly tell the attending physician, “Doctor, thank you for this information. But Aunt Millie is just fine right now. I read the postings of some Alzheimer’s experts who said that the Anavex drug should never be used on anyone not showing real symptoms. Using the drug that way would be profillaxis or something, and that’s just wrong; shouldn’t be allowed. We’ll wait until Aunt Millie really needs that new drug.”

[Steady_T]

Very much in keeping with my post about 2-73 being prescribed as a prophylactic although one could argue that this is really just a very early diagnosis and not a prophylactic use.